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ABSTRACT : In order to evaluate the factors affecting the patient's survival, 32 
patients of hepatic resection in which the liver had a sollitary hepatocellular car-
cinoma (HCC) smaller than 5 cm in size were studied. 1) Chronic liver diseases were 
associated in 96.9 % of patients. Minor resection was done in 30 patients, and right 
hepatectomy in two. 2) 87.5 % of all cases were diagnosed during periodic follow-up 
examination for the patients with chronic liver disease, mostly cirrhosis. For small 
HCC, ultrasonography (US) had the highest detection rate (90%) compared with CT 
(66.7%) and angiography (55.6%). Preoperative serum AFP values were abnormal 
in 73%. 3) Grossly, all tumors were nodular or expanding and none was diffuse. 
Encapsulation appeared to be complete as tumor grew. Portal vein tumor thrombus 
(12.5%) and/or satellite tumor (31.2%) were frequent in those with larger than 2 cm 
in diameter. 4) The mortality rate was 9.4% and the hospital mortality rate was 6.3 
%. The survival rate of the group with small HCC was far better than that of the 
groups with HCC larger than 2 cm in size (p<0.05 ). Above findings indicate that 
early detection of the tumor without portal vein thrombus and/or satellite tumor, 
and an adequate hepatic resection such as subsegmentectomy or segmentectomy are 
most improtant for the patient's survival.
       INTRODUCTION 
 Prognosis of hepatocellular carcinoma (HCC) 
has been extremely poor, because of the frequen-
cy of underlying liver diseases, malignant nature 
of tumor which spreads to the portal vein or 
entire liver even at the early stage, and diffi-
culty of early detection. According to the study 
of the Japan Liver Cancer Study Group,1) over-
all survival rate after the onset of disease was 
21.5% in one year, and 2.4% in five years. 
Recently, with the progress in diagnostic proce-
dures such as ultrasonograpy (US), computed 
tomography (CT) and angiography, small HCC 
can be detected, and early surgery in suitable 
patients have increased. However, the resectabili-
ty rate of HCC has remained rather low, mainly 
because of coexisting cirrhosis which results in 
fatal complications after surgery. Therefore, 
standard major liver resections in cirrhosis 
have an operative mortality of 20.7% to 60%,. 
much higher than in patients with non-cirrhotic 
livers. 2-5 ) We have previously reported that 
the major hepatic resection more than two seg-
ments of cirrhotic liver facilitated degeneration
of liver cells, and most of these patients died 
from hepatic failure rather than recurrent tu-
mor.6) The purpose of this study is to investi-
gate the pathological features of HCC which 
might affect the patient's survival, with refer-
ence to surgical procedures, and to assess the 
utility of imaging modalities in detection of 
small HCC. 
   MATERIALS AND METHODS 
 From January 1975 to December 1987, 32 
patients with HCC smaller than 5cm in diameter, 
who underwent resection at The First Depart-
ment of Surgery, Nagasaki University Hospital, 
were studied. Among them, 11 p.-itients had tu-
mors smaller than 2cm (group A), eight had 
tumor between 2 and 3cm (group B ), and 13 
had tumor between 3 to 5cm (group C). There 
were 28 men and four women ranging from 39 
to 74 years of age, with an average of 54.8 
years. In preoperative clinical status, 25 had 
Child's class A and seven had class B liver dis-
ease. Twenty-four of the HCC were located in 
the right lobe and 8 in the left lobe. Cell differ-
entiation of the tumors were graded according 
to the criteria suggested by Edmondson and 
Steiner.71Underlying liver diseases were separat-
ed into categories of cirrhosis, precirrhosis, 
chronic hepatitis and normal.8) HCC smaller 
than 2cm is defined as small HCC in this paper. 
          RESULTS 
Clinical Features 
 Diagnostic Clue: In 28 of 32 patients (87.5%), 
tumor was detected during follow-up examina-
tion for underlying liver disease. Two patients
were diagnosed during gastric ulcer operation 
and one patient underwent emergency operation 
due to spontaneous rupture of tumor. 
 Elevation of serum AFP levels during the 
follow-up of chronic liver disease led to tumor 
detection in 18 of 28 follow-up patients (64.3%). 
US performed at the time of periodic check-up 
of patients with liver cirrhosis or abnomal liver 
function tests, detected tumors in 10 patients 
(35.7%). 
 Diagnostic Capability of Various Imaging 
Modalities: The detection for HCC smaller than 
5cm in diameter with US, CT and angiography 
were shown in Table 1. For small HCC, US had 
the highest detection rate (90%) compared with 
CT (66.7%) and angiography (55.6%) (Fig. 1). 
For group B, differences in detection rate be-
came smaller. All HCC of group C were detect-
ed with each imaging modality. 
 AFP and HBsAg: The frequencies of positive 
serum AFP and HBsAg of the patients were 
tabulated in Table 2. In 73 % of all cases, the 
serum AFP value was abnormal, i.e., more than 
20ng/ml, and in 28.1 % of total cases it was 
more than 400ng/ml. Only one of the patients 
with group A had serum AFP levels of more 
than 400ng/ml, but such levels were detected 
in 50% and 30.3% of patients with group B and 
C, respectively. 
 Serum HBsAg was detected in 31.3% of all 
patients. As shown in Table 2, 9.1% of patients 
with group A, 75% with group B, and 23% with 
group C showed abnormal serum HBsAg. 
Pathologic Features 
 Underlying Liver Diseases: 31 of 32 patients 
(96.9%) had chronic liver diseases as follow: 
chronic hepatitis, two cases (6.3%); precirrhosis,
Table 1. Diagnostic Capability of Various Imaging Modelities for Hepatocellular 
       Carcinoma by Tumor Size (<5 cm) 
                             No. of patients with positive results (%) 
   Imaging modality Tumor size 
                          < 2cm 2-3 cm 3-5 cm Total 
Ultrasonography 9/10 (90.0) 7/8 (87.5) 11/11 (100) 27/29 (93.1) 
Computed tomography 6/ 9(66.7) 6/8 (75.0) 11/11 (100) 24/29 (82.8) 
Angiography 5/ 9 (55.6) 7/8 (87.5) 13/13 (100) 25/29 (86.2)
Fig. 1. Preoperative ultrasonogram of small HC 
      C showing 1.5 X 1.7 cm hypoechoic lesion
      (arrow) with a sonolucent thin rim or 
      periphery around it.
four cases (12.5%) ; and liver cirrhosis, 25 cases 
(78.1 % ) (Table 3 ). The presence of advanced 
liver cirrhosis appeared to be highly associated 
with group A and B, in which 90.9% and 87.5% 
of cases had liver cirrhosis, respectively. 
 Histologic Findings of Tumor: The most fre-
quent histologic type of HCC was the grade II , 
which was found in 14 tumors from 29 patients 
excluding three cases with complete tumor nec-
rosis because of TAE (Table 3 ). One half of 
small HCC showed low grade differentiation. 
Tumor size in general tends to increase with tu-
mor anaplasia. The combined type was encoun-
tered in only one case, which composed of con-
tinuous hepatocellular and ductal carcinoma. 
 As for gross appearance of tumor, all were 
nodular or expanding, and none was diffuse. The 
features of capsule formation and capsule inva-
sion of HCC were shown in Table 4. There were 
two cases with no capsule formation in small 
HCC. Grossly these tumors were formed by a 
cluster of small and contiguous nodules, with 
fibrous connective tissues evident at the borders 
of each nodule, often with replacing growth at 
the periphery. A thin fibrous capsule surround-
ing the tumor was found in six of all cases 
(18.8%)(Fig. 2). 12 of 13 cases (92.3%) in group
     Table 2. Serum Hepatitis B Surface Antigen (HBsAg) and a-Fetoprotein (AFP) 
                          Status of HBsAg Level of serum AFP (ng/ml) T
umor No. of No. (/o) 
 size patients - + Positive 
rate (%) < 20 20 - 400 400 < 
<2 cm 11 10 1 9.1 4 (36.4) 6 (54.5) 1 ( 9.1) 
2-3 cm 8 2 6 75.0 2 (25.0) 2 (25.0) 4 (50.0) 
3-5 cm 13 10 3 23.1 2 (15.4) 7 (53.8) 4 (30.8)
                Table 3. Histologic Grade and Underlying Liver Diseases 
                     Grade of differentiation* Histologic finding of 
 Tumor No. of No. (%) noncancerous liver. No. (%) 
  size patients I II III CM NC CH PC LC 
 <2 cm 11 5 (50.0) 2 (20.0) 3(30.0) 0 0 1 (9.1) 0 10 (90.9) 
2-3 cm 8 1 (12.5) 4 (50.0) 2 (25.0) 1 (12.5) 0 0 1 (12.5) 7 (87.5) 
3-5 cm 13 0 8 (72.8) 3 (27.3) 0 1 (7.7) 1 (7.7) 3 (23.1) 8 (66.7) 
* Based on evaluation of 29 cases excluding 3 cases with complete tumor necrosis. CM : combined 
with HCC and cholangioma ; NC : no liver disease ; CH : chronic hepatitis ; PC : precirrhosis ; 
 LC : liver cirrhosis
             Table 4. Capsule Formation (fc) and Capsule Invasion (fc-inf) of HCC 
Tumor No. of Status of fc Status of fc-inf 
 size patients - +/- + Positive - + ++ Positive                                         rate (/o) rate (/o ) 
<2 cm 11 2 3 6 54.5 7 4 0 0 
2-3 cm 9 0 2 7 77.7 1 0 8 88.8 
3-5 cm 13 0 1 12 92.3 2 1 9 69.2 
Capsule ; (-) no capsule ; (+ / -) the mass is surrounded by fibrous capsule, but incomplete 
(+) the mass is firmly encapsulated with fibrous tissue. 
Capsule invasion ; (-) no invasion ; (+) Intracapsule invasion ; (+ +) cancer invases extending 
through capsule.
Fig. 2. Cut surface of small HCC showing 1.9 X 
      1.5 cm gray-white tumor which is incom-
      pletely lobulated into several parts.
Fig. 3. Histological findings showing portal 
       vein thrombus. (H. E. X36)
C had the firmly encapsulated tumor which 
demonstrated expansive growth. Capsule for-
mation appeared to become complete as tumor 
grew. High incidence of invasion of HCC extend-
ing through capsule was noted in group B (88.9 
  )and group C (69.2 % ), whereas, there was 
no evidence of capsule invasion in small HCC 
excluding one case with intracapsular invasion. 
 The presence of tumor thrombus in the portal 
vein was detected in 10 cases (31.3 %) (Fig. 3), 
and satellite tumor adjacent to main mass was
found in four cases (12.5%). Their distribution 
was shown in Table 5. Small HCC were not asso-
ciated with tumor thrombus and satellite tumor. 
Operative Procedures 
 All tumors of 32 patients were surgically re-
moved (Table 6). The operations were consider-
ed radical in all patients judged by intraopera-
tive findings and postoperative US or CT. 
Right lobectomy was performed in two cases 
with precirrhosis and normal liver, respectively.
      Table 5. Incidence of Portal Tumor Thrombus and Satellite Tumor 
Tumor Tumor thrombus Satellite tumor 
                             Positive Positive 
 size - + 
rate (%) + rate (%) 
<2 cm 11 0 0 11 0 0 
2-3 cm 4 5 55.6 8 1 11.1 
3-5 cm 8 5 38.5 10 3 23.1
Table 6. Surgical Procedures in 32 Patients with 
     HCC 
          Method No. of patients 
Enucleation 2 
Partial hepatic resection 7 
Subsegmentectomy 12 
Segmentectomy 
  Posterior 1 
  lateral 8 
right lobectomy 2 
          Total 32 
Limitid hepatic resection which composed of 
enucleation and partial wedge resection was done 
in 12 cases with advanced cirrhosis. In recent 
21 cases, segmental (Healey's segment) and sub-
segmental (Couinaud's segment) resections us-
ing intraoperative ultrasonography were carried 
out. In 15 of all cases (46.9% ), less than one 
cm of liver parenchyma surrounding the tumor 
was removed. 
Postoperative Morbidity and Mortality 
  Five patients had postoperative complicaions: 
hepatic failure, postoperative bleeding, post-
operative ileus and right hemothorax, respec-
tively. Two patients with right hemothorax 
were successfully treated by conservative meth-
ods, but two patients with postoperative bleed-
ing and one with postoperative ileus died from 
hepatic failure within one month. Two patients 
died without discharge from hospital, within 
three months and four months, because of se-
vere cirrhosis. The operative and in-hospital 
mortality rates were thus 9.4% and 6.3%, re-
spectively. 
Survival 
  Twenty-seven patients were discharged from 
hospital. At present, 17 patients are alive with 
no sign of cancer during the periods from seven 
months to nine years after operation. Six 
patients died of tumor recurrence and four from 
hepatic failure after discharge. Cumulative 
survival rate (Kaplan-Meier method) of three 
groups excluding three cases of operative death 
were shown in Fig. 4. Significant differences 
(p<0.05) were seen among group A and group 
B and C, three years after surgery. The 3-year
Fig. 4. Cumulative survival rates in 9 patients 
      with small HCC (group A ), 7 patients 
      with HCC of 2 -3 cm (group B) and 11 
      patients with HCC of 3-5 cm (group C). 
survival rate was 71.7% in group A, 38.9% in 
group B and 30.0% in group C. 
         DISCUSSION 
 Recent advanced imaging modalities and serum 
AFP measurement in patients at risk made it 
possible to detect small hepatocellular carcino-
ma (HCC).9"° This had led to the significant 
improvement in the management of cirrhotic 
patients with HCC. 11,12) In our preveous series,6) 
most of the patients have been admitted with 
tumor-associated symptoms as described by 
Berman's classification.13) In the current series 
(tumor less than 5cm in diameter), almost all 
patients had no symptoms or signs, and were 
diagnosed during periodic follow-up examina-
tion for their underlying liver disease. Serum 
AFP measurement has been the most frequently 
used screening test for the diagnosis of HCC, 
even in the group without symptoms.`,1 o) How-
ever, 53.1 % of our patients had normal or 
slightly elevated AFP levels below 100ng/ml, 
and serum AFP levels were the first clue to di-
agnosis in only 35.7%. AFP levels below 400ng 
/ml were not specific for HCC, unless a pro-
gressive increase has been observed. 1) There-
fore, the utility of AFP measurement in the 
diagnosis of small HCC has some limitation. 
Serum HBsAg was detected in 31.3 % of our 
patients. The patients with positive IIBsAg are 
the most important high risk groups, but the 
frequency of positive test for HBsAg was low 
among the patients of HCC. The positive rates
of HCC in Japan series reported by The Liver 
Cancer Study Group of Japan was 34.1%.2) 
 In the present series, US, CT and angiography 
proved to be most useful in the diagnosis of 
asymptomatic patients. Of these diagnostic 
modalities available, US has had greater than 
90% sensitivity of detection in small HCC, and 
also can evaluate pathological features of the 
tumor and its location. Almost all the small 
HCC were hypoechoic with some weak central 
echogenecity, reflecting the pathological fea-
tures such as encapsulation and tumor paren-
chyma without necrosis. Angiography can pro-
vide useful information on the vascular supply 
of the tumor, and also can be utilized for the 
therapy of transcatheter embolization for tu-
mor. 15) However, our five patients with tumors 
less than 3cm in diameter were not detected by 
angiography. These findings are assumed to 
reflect the pathological features of small HCC 
in which tumor encapsulation and vasculality 
of tumor were feasible. It was reported in Japan 
series that in 21 of 720 cases (2.9%) hepatic tu-
mors were not visualized on arteriograms and 
the technical problems of angiography probably 
account for the non-visualization of these tu-
mors.2) 
 In previous reports, we have identified several 
important pathological features of the tumor 
affecting the prognosis after surgery, even when 
the tumor is diagnosed at an early stage. 16 ) 
These include the size of the tumor, the finding 
of the portal vein tumor thrombus, the presence 
of satellite tumors, an adequate resection mar-
gin and tumor encapsulation. In the current 
series, we confirmed this fact by an analysis 
of many patients. In patients with tumor larger 
than 2cm in size, invasion of the small portal 
branchs, or the presence of satellite tumors 
were frequently recognized with lower survival 
rates when compared to that of small HCC. 
The reported positive rates of several pathologi-
cal factors of small HCC in large series in Japan 
were 47.1%-89% in tumor encapsulation, 67%-
75% capsule invasion of tumor, 10%-22% por-
tal tumor thrombus and 25 %-35.3 % satellite 
tumor. 17-20) 
 For hepatic resection of HCC, the important 
factors are these pathological features and the 
presence of coexisting cirrhosis. Standard major
liver resection is poorly tolerated in cirrhosis, 
because of impaired regeneration of residual 
liver tissues as the results of postoperative 
hepatic failure. In our previous series, the oper-
ative mortality in cirrhotic patients with major 
hepatectomy were 46.7%, and 75% of follow-
up patients died from hepatic failure. 6) There-
fore, in current series, we performed wedge 
resection or subsegmental resection which were 
described by MAKUucI I et al., 11) with good results. 
We also recognized that, survival rates of small 
HCC were far better than that of the HCC larg-
er than 2cm in diameter, even in the presence 
of several pathological factors affecting prog-
nosis. It is to be emphasized that early detec-
tion of small HCC and an adequate hepatic resec-
tion such as subsegmentectomy or segment-
ectomy, quantitative evaluation of functional 
reserve of the liver in cirrhotic patients, are 
most important for the survival of the patients. 
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